Influenza vaccination and fetal and neonatal outcomes

Medicine and Dentistry

• Influenza Vaccination 100%
• Influenza Vaccine 50%
• Disease 25%
• Observational Study 25%
• High Risk Population 25%
• Randomized Clinical Trial 25%
• Vaccine 25%
• Pharmacovigilance 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Vaccination Policy 100%
• Live Attenuated Influenza Vaccine 40%
• Observational Study 20%
• Disease 20%
• Influenza Vaccine 20%
• Randomized Clinical Trial 20%
• Vaccine 20%
• Pharmacovigilance 20%

Keyphrases

• Post-marketing Pharmacovigilance 25%